571 Results (Page 20 of 23)
UK Markets Research Reports
UK Hospital Acquired Infection (HAI) control Market Analysis
UK Hospital Acquired Infection (HAI) Control Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospital Acquired Infection (HAI) Control is expanding as a result of rising population of elderly along with chronic diseases and growing prevalence of hospital acquired infections. This demand is fueling the development of better control methods for the hospital acquired infections. Some of the key players in the global Hospital Acquired Infection (HAI) Control Market include 3M Company, STERIS plc, Getinge AB, Advanced Sterilization Products, Ecolab Inc., MATACHANA GROUP, Belimed AG, Reckitt Benkiser, Contec Inc., Miele Group, and MMM Group.
UK Hospital Information System Market Analysis
UK Hospital Information System Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospital Information System is expanding as a result of rising government spending and implementation of healthcare IT solutions. This demand is fueling the development of better Hospital Information system for the efficient management of patient data. Some of the key players in the global Hospital Information System Market include Allscripts Healthcare, LLC, Cerner Corporation, Dedalus S. p. A., GE Healthcare, Integrated Medical Systems, Inc., Koninklijke Philips N.V., McKesson Corporation, NXGN Management, LLC, Siemens Healtineers AG, and Wipro Limited.
UK Hospitals and Outpatient Care Centers Market Analysis
UK Hospitals and Outpatient Care Centers Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospitals and Outpatient Care Centers is expanding as a result of rising demand for healthcare services and technological advancements. This demand is fueling the development of better Hospitals and Outpatient Care Centers. Some of the key players in the global Hospitals and Outpatient Care Centers Market include Kaiser Permanente, UnitedHealth Group Incorporated, HCA Healthcare, Tenet Healthcare, Fresenius Medical Care AG & Co. KGaA, Mayo Clinic, Community Health Systems, Cleveland Clinic, DaVita Inc., Ramsay Health Care, and Medtronic.
UK ICU Beds Market Analysis
UK ICU Beds Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for ICU Beds is expanding as a result of rising healthcare spending, growing geriatric population, and increasing prevalence of chronic diseases. This is boosting the growth of ICU Beds market. Some of the key players in the global ICU Beds Market Hill-Rom Holdings, Inc., Getinge AB, Linet Spol. S. R. O., Stiegelmeyer GmbH & Co. Kg, Stryker Corporation, Medline Industries, Inc., Invacare Corporation, Amico Corporation, Midmark Corporation, LINAK A/S, Melivaara Corp., and Nitrocare.
UK In-Vitro Colorectal Cancer Screening Tests Market Analysis
UK In-Vitro Colorectal Cancer Screening Tests Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for In-Vitro Colorectal Cancer Screening Tests is expanding as a result of rising incidence of colorectal cancer. The rise in awareness regarding the in-vitro colorectal cancer screening test and the increased use of biomarkers are projected to proliferate the market. Some of the key players in the global In-Vitro Colorectal Cancer Screening Tests Market include Immunostics Inc., Abbott, Beckman Coulter, Inc., Sysmex Corporation, Siemens Healthcare Private Limited, Clinical Genomics Technologies Pty, Ltd., Epigenomics AG, Quest Diagnostics Incorporated, Eiken Chemical Co, Ltd., Merck KGaA, Hemosure, Inc., Novigenix SA, and Alere, Inc.
UK Infectious Disease Diagnostic Market Analysis
UK Infectious Disease Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Infectious disease diagnostics is expanding as a result of rising prevalence of infectious diseases. This demand is driving the market for better diagnostics services for infectious diseases and methods for the early detection and accurate diagnosis of infectious disease. Some of the key players in the global Infectious Disease Diagnostics Market include Thermo-Fisher Scientific Inc., Hologic, Inc., Abbott, Bio-Rad Laboratories, Inc., OraSure Technologies, Inc, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Chembio Diagnostics, Inc., Danaher Corporation, and Becton, Dickinson and Company.
UK Influenza Diagnostic Market Analysis
UK Influenza Diagnostic Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Influenza diagnostics is expanding as a result of rising healthcare spending in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of Influenza. Some of the key players in the global Influenza Diagnostics Market include 3M; Abbott Laboratories, Inc.; Becton, Dickinson, and Company (BD); Meridian Bioscience, Inc.; Quidel Corporation; F. Hoffmann-LA Roche AG; SA Scientific; Sekisui Diagnostics; Thermo Fisher Scientific, Inc.; Hologic, Inc.
UK Cancer Immunotherapy Market Analysis
The UK cancer immunotherapy market is expected to grow from $2.9 Bn in 2022 to $4.3 Bn in 2030 with a CAGR of 5.1% for the forecasted year 2022-2030. The new scientific developments in cancer immunotherapies and growing awareness about immunotherapy options in the UK are responsible for the expansion of the market. The UK cancer immunotherapy market is segmented by type, application, and end user. Ervaxx, Immunocore, and Amgen are the major players in the UK cancer immunotherapy market.
UK Connected Healthcare Market Analysis
The UK-connected healthcare market is projected to grow from $1.73 Bn in 2022 to $11.24 Bn by 2030, registering a CAGR of 26.24% during the forecast period of 2022-2030. The main factors driving the growth would be the ageing population, advances in technology, the COVID-19 pandemic and regulatory support. The market is segmented by type, function and by application. Some of the major players include Babylon Health, Huma, Livi, Pudh Doctor, Cera Care, Apple, Microsoft, IBM and GE Healthcare.
UK Radiotherapy Market Analysis
By 2030, it is anticipated that the UK Radiotherapy Market will reach a value of $7.7 Bn from $4.7 Bn in 2022, growing at a CAGR of 6.4% during 2022-30. The Radiotherapy Therapeutics Market in the UK is dominated by a few domestic players such as Alpha Omega Services, Curium Pharma, and Oncology Systems Limited. The radiotherapy market in the UK is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for UK Radiotherapy is increasing on account of the rise in cancer cases in the country.
UK Breast Cancer Therapeutics Market Analysis
The UK breast cancer therapeutics market is at around $473 Mn in 2022 and is expected to witness a growth of $1,083 Mn with a CAGR of 10.9% for the year 2022-2030. The major market drivers include the rising prevalence of breast cancer and its awareness programs in the UK. The market is segmented by therapy, by cancer type, and by distribution channel. Pfizer, AstraZeneca, and Bayer are some of the leading brands in the UK breast cancer therapeutics market.
UK Dialysis Market Analysis
The UK dialysis market size was valued at $3.02 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.5 Bn in 2030. Some of the major factors driving the market are increased funding for the research of novel medications, and an increase in patients with end-stage renal disease (ESRD). The market is segmented by Type, Product and Services, and End User. The major market players in the UK dialysis market are DaVita, Baxter, Medtronic, Fresenius Kabi, Physidia, and others.
UK Teleradiology Market Analysis
The UK Teleradiology market size was valued at $62 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.7% from 2022 to 2030 and will reach $ 129 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The UK telerdiology market will grow due to Increasing demand for remote radiology services. The key market players are Medica Group PLC, Radiology Reporting Online (RRO), Telemedicine Clinic (TMC), Imaging Insight, and others.
UK Pain Management Devices Market Analysis
This report presents a strategic analysis of the UK Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
UK Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the UK Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
UK Electronic Records Management Solutions Market Analysis
The UK electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. UK’s Electronic Records Management Solutions market will grow to promote the adoption of electronic records management tools in healthcare organizations, the UK government has launched a number of programs. The key market players are Access Intelligence (GBR), Agile ECM (GBR), Cleardata UK Ltd (GBR), EDM Group (GBR), ELO Digital Office (DEU)others.
UK ECG Equipments Market Analysis
The UK ECG Equipment Market is expected to witness growth from $232 Mn in 2022 to $350 Mn in 2030 with a CAGR of 5.30% for the forecasted year 2022-2030. The main cause of mortality in the UK is cardiovascular disease, and as the population ages and people lead unhealthy lifestyles, the prevalence of these diseases is rising. As a consequence, there is an increasing need for ECG equipment that can be used to identify and track these conditions. The market is segmented by product type and by the end user. Some key players in this market include LivaNova, Win Health Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
UK Depression Therapeutics Market Analysis
The UK depression therapeutics market is expected to witness growth from $263 Mn in 2022 to $338 Mn in 2030 with a CAGR of 3.2% for the forecast year 2022-2030. The rising cases of depression in the UK particularly in the younger generation and their subsequent demand for novel therapeutic options are responsible for the growth of the market. The UK depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Curium Pharma, Chatfield Pharmaceuticals, and Abbott Laboratories are the major players in the UK depression therapeutics market.
UK Biomaterials in Healthcare Market Analysis
The UK Biomaterials Healthcare Market is expected to witness growth from $4.06 Bn in 2022 to $9.49 Bn in 2030 with a CAGR of 11.20% for the forecasted year 2022-2030. In the UK, the prevalence of chronic illnesses like osteoarthritis, diabetes, and cardiovascular disease is rising. The demand for biomaterials in the healthcare sector is being driven by the ability to use them to make medical implants and devices that can aid in the management of these diseases. The market is segmented by type and by application. Some key players in this market include Camstent, Renovos Biologics, Collagen Solutions, BASF SE, Celanese, and Evonik Industries.
UK Anti Aging Therapeutics Market Analysis
UK anti-aging therapeutics market is projected to grow from $16 Mn in 2022 to $46 Mn in 2030 with a CAGR of 14.53% for the year 2022-2030. The rising geriatric population, increasing demand for anti-aging therapeutics, and rising healthcare expenditure are the major market drivers for the growth of the market. The UK anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Veristat, Genflow Biosciences, and Regenerative Medicine.
UK Healthcare Financial Analytics Market Analysis
The UK Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UK’s Healthcare Financial Analytics market will grow the adoption of EHRs has been increasing in the UK healthcare sector. Financial analytics solutions can integrate with EHRs to provide a comprehensive view of a patient's health history and enable better decision-making. The key market players are Draper & Dash, MedeAnalytics, Informatics Merseyside, EY, and others.
UK Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UK Liver Disease Therapeutics market will reach a value of $803 Mn from $600 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. Liver Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as Intercept Pharmaceuticals, Gilead Sciences, AstraZeneca and Shire. The Liver Disease Therapeutics market in the UK is segmented into different types of disease and different therapy types. Some of the major factors affecting the UK Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UK Diabetes Drugs Market Analysis
The UK diabetes drugs market size was valued at $1.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030 and will reach $2.21 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The UK diabetes drug market will grow because UK has a strong pharmaceutical industry with several established companies and emerging biotech companies developing new diabetes drugs. The key market players are AstraZeneca, GlaxoSmithKline, Eli Lilly and Company, Novo Nordisk, Sanofi, and others.
UK Robotic Surgery Services Market Analysis
UK robotic surgery service market size was valued at $112 Mn in 2022 and is estimated to expand at a CAGR of 17.30% from 2022-30 and will reach $400 Mn in 2030. The robotic surgery service market will grow due to Robotic surgical systems providing physicians with greater accuracy and precision, which results in improved patient outcomes and reduced complications. The market is segmented by product and service type, application type, and end user. Some of the major players are Intuitive Surgical, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., and others
UK Neurology Clinical Trials Market Analysis
The UK Neurology Clinical Trials market is projected to grow from $342.2 Mn in 2022 to $451.4 Mn by 2030, registering a CAGR of 3.52% during the forecast period of 2022 - 2030. The market will be driven by increasing funding and assistance from institutions such as the NIHR as well as greater awareness and understanding of neurological disorders. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Biogen Inc & Cambridge Cognition Holdings PLC.
